Visualize how your peptide clears from the body — half-life, steady state, and accumulation for every injection schedule.
Half-Life
~4 h
Time for 50 % to be eliminated
Steady State
~17 h
≈ 4.3 half-lives
Accumulation
×1.02
Cmax at steady state ÷ Cmax first dose
Gone After
~1.2 days
after last dose
Source: Sikiric et al., animal PK studies. Research tool. Uses a simplified first-order elimination model and normalizes concentration to % of peak. Not a medical or dosing recommendation. BPC-157: ~4 h.
BPC-157 has a reported half-life of about 4 hours. Under a daily dosing schedule, steady state is reached at roughly 4.3 half-lives — about 17 hours — and accumulation is essentially negligible: each daily dose clears almost fully before the next.
The blue line plots concentration as a percentage of the first-dose peak. The dashed reference line marks the steady-state peak. After the last dose, concentration drops below 1 % of the peak after about 28 hours — seven half-lives.
BPC-157 is a research peptide studied for tissue repair and cytoprotection. Typical daily doses in animal studies range from 0.2 to 0.5 mg. Because the short half-life produces virtually no accumulation, each dose acts independently, and the pharmacokinetic profile is straightforward.